Related Experiment Videos
[Cardiac dysfunction in children with thalassemia major].
L Angelika1, N Graf, W Hoffmann
1Kardiologischen Abteilung, Universitäts-Kinderklinik, Homburg/Saar.
Klinische Padiatrie
|March 1, 1988
Summary
Beta-thalassemia major patients experienced cardiac issues, including arrhythmias, particularly older individuals. Improved compliance with chelation therapy is crucial to prevent iron toxicity and protect cardiac function.
Area of Science:
- Cardiology
- Hematology
Context:
- Beta-thalassemia major is a severe inherited blood disorder.
- Cardiac complications, including iron overload, are common in beta-thalassemia major patients.
Purpose:
- To evaluate cardiac function in patients with beta-thalassemia major.
- To assess the impact of exercise on cardiac function in these patients.
- To identify potential cardiac risks associated with the condition.
Summary:
- Continuous electrocardiography, echocardiography, and radiocardiography were used to assess cardiac function in seven patients.
- Older patients (17 and 20 years) showed serious arrhythmias and reduced left ventricular function during rest and exercise.
- Younger patients were asymptomatic with normal cardiac function tests.
Impact:
- Findings highlight the need for vigilant cardiac monitoring in beta-thalassemia major patients.
- Enhanced patient compliance with chelation therapy is essential to prevent transfusion-related cardiac iron toxicity.
- Early detection and management of cardiac dysfunction can improve patient outcomes.